0.71  0.017 (2.45%)		06-22 16:00
Open: 0.6722 High: 0.71 Volume: 298,445		Pre. Close: 0.693 Low: 0.66 Market Cap: 31(M)

Short term
Mid term
Targets	6-month :	1.39	1-year :	1.77
Resists	First :	1.19	Second :	1.51
Pivot price	0.83
Supports	First :	0.66	Second :	0.54
MAs	MA(5) :	0.72	MA(20) :	0.89
	MA(100) :	1.31	MA(250) :	1.97
MACD	MACD :	-0.2	Signal :	-0.2
%K %D	K(14,3) :	7.6	D(3) :	5.9
RSI	RSI(14): 25.8
52-week	High :	3.83	Low :	0.66

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ HEXO ] has closed above bottom band by 17.9%. Bollinger Bands are 13.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	0.71 - 0.72	0.72 - 0.72
Low:	0.65 - 0.65	0.65 - 0.66
Close:	0.7 - 0.71	0.71 - 0.72

HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. HEXO Corp. has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada.

Fri, 13 Jun 2025
Québec Court of Appeal dismisses Hexo Securities class action | Canada | Global law firm - Norton Rose Fulbright

Wed, 26 Mar 2025
US court dismisses Tilray/HEXO shareholder lawsuit - StratCann

Wed, 26 Mar 2025
Court Victory: Tilray Defeats $8M Shareholder Lawsuit Over HEXO Acquisition - Stock Titan

Wed, 26 Mar 2025
Tilray Successfully Prevails with Dismissal of HEXO Shareholder Lawsuit - GlobeNewswire

Sun, 01 Sep 2024
Tyson 2.0 Partners with Hexo to Bring Product Line to Canada - Ganjapreneur - Ganjapreneur

Fri, 23 Jun 2023
Marijuana company Tilray closes Hexo acquisition, eyes cost savings - MJBizDaily

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Shares Out	44 (M)
Shares Float	38 (M)
Held by Insiders	3 (%)
Held by Institutions	7.5 (%)
Shares Short	972 (K)
Shares Short P.Month	1,130 (K)

EPS	-1.52
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	5.88
Profit Margin	-203.3 %
Operating Margin	-115.4 %
Return on Assets (ttm)	-14.3 %
Return on Equity (ttm)	-83.5 %
Qtrly Rev. Growth	-54.3 %
Gross Profit (p.s.)	-1.72
Sales Per Share	3.36
EBITDA (p.s.)	-3.25
Qtrly Earnings Growth	0 %
Operating Cash Flow	-48 (M)
Levered Free Cash Flow	168 (M)

PE Ratio	-0.47
PEG Ratio	0
Price to Book value	0.12
Price to Sales	0.21
Price to Cash Flow	-0.65

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.